Literature DB >> 8345044

Pulsatile secretion of parathyroid hormone in normal young subjects: assessment by deconvolution analysis.

M H Samuels1, J Veldhuis, C Cawley, R J Urban, M Luther, R Bauer, G Mundy.   

Abstract

Preliminary reports suggest that PTH is secreted in a pulsatile fashion. However, available studies have not attempted to calculate actual PTH secretion rates in healthy individuals. To accurately characterize PTH secretory dynamics in healthy subjects, we studied seven young women and six young men, all of whom had hip and spine bone densities by dual photon densitometry in the upper tertile for age-matched control subjects. PTH concentrations were measured by immunoradiometric assay in blood sampled every 2 min over 6 h. Ionized calcium levels were obtained during the second and third hours of the study. Plasma PTH profiles were subjected to deconvolution analysis, which resolves measured hormone levels into secretion and clearance components. Cross-correlation analysis was performed to assess direct or inverse correlations between serum PTH and ionized calcium concentrations at various time lags. In these subjects, PTH was secreted in a dual fashion, with significant basal (tonic) secretion and PTH pulses approximately every 20 min. Pulsatile PTH secretion accounted for approximately 25% of the total secreted PTH. There were no differences in PTH secretory parameters between men and women, nor were there any significant correlations between PTH and ionized calcium concentrations. We conclude that in normal subjects, the predominant mode of PTH secretion is tonic, with superimposed PTH pulses of small amplitude but high frequency. The clinical significance of this complex physiological pattern of secretion awaits further study.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8345044     DOI: 10.1210/jcem.77.2.8345044

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

2.  Bone mineral content, corrected for height or bone area, measured by DXA is not reduced in children with chronic renal disease or in hypoparathyroidism.

Authors:  S Faisal Ahmed; Shiuli Russell; Rajeeb Rashid; T James Beattie; Anna V Murphy; Ian J Ramage; Heather Maxwell
Journal:  Pediatr Nephrol       Date:  2005-07-27       Impact factor: 3.714

3.  Predicting PTH pulses and patterns in osteoporosis.

Authors:  L J Deftos; S J Schiff
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 4.  Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology.

Authors:  Donovan Tay; Serge Cremers; John P Bilezikian
Journal:  Br J Clin Pharmacol       Date:  2017-12-06       Impact factor: 4.335

5.  Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism.

Authors:  Karen K Winer; Bo Zhang; Joseph A Shrader; Donna Peterson; Michaele Smith; Paul S Albert; Gordon B Cutler
Journal:  J Clin Endocrinol Metab       Date:  2011-11-16       Impact factor: 5.958

Review 6.  Teriparatide administration by the Omnipod pump: preliminary experience from two cases with refractory hypoparathyroidism.

Authors:  Karine Aouchiche; Rachel Reynaud; Vincent Amodru; Thierry Brue; Thomas Cuny
Journal:  Endocrine       Date:  2022-01-04       Impact factor: 3.925

Review 7.  Glucocorticoid-induced osteoporosis: pathophysiology and therapy.

Authors:  E Canalis; G Mazziotti; A Giustina; J P Bilezikian
Journal:  Osteoporos Int       Date:  2007-06-14       Impact factor: 4.507

8.  Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism.

Authors:  Karen K Winer; Kara A Fulton; Paul S Albert; Gordon B Cutler
Journal:  J Pediatr       Date:  2014-06-16       Impact factor: 4.406

9.  Parathyroid function in cardiac transplant patients: evaluation during physical exercise.

Authors:  G Brandenberger; B Schnedecker; K Spiegel; B Mettauer; B Geny; J Sacrez; E Lampert; J Lonsdorfer
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

10.  Clinical characteristics and depression score response after parathyroidectomy in primary hyperparathyroidism.

Authors:  Ann E Kearns; Rachel P Espiritu; Kristin Vickers Douglass; Prabin Thapa; Robert A Wermers
Journal:  Clin Endocrinol (Oxf)       Date:  2019-06-25       Impact factor: 3.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.